📰 Us Development News
Page 63 - Us Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Us Development. Real-time updates on events, politics, business and more.
December 20, 2022
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
December 19, 2022
Study HPN-PSR-01 opens patient enrollment PRINCETON, N.J., Dec. 19, 2022 /PRNewswire/ -- Soligenix, Inc. SNGX (Soligenix or the Company), a late-stage
December 15, 2022
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
November 15, 2022
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
November 10, 2022
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
October 27, 2022
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
October 25, 2022
Phase 2a clinical study in mild-to-moderate psoriasis initiating in December 2022PRINCETON, N.J., Oct. 25, 2022 /PRNewswire/ -- Soligenix, Inc. (N...
October 20, 2022
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
October 17, 2022
Interviews to air on national television including Fox Business and Bloomberg, as a Sponsored Program...
September 23, 2022
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...